News Join our mailing list to receive our quarterly email newsletter with news, updates and events in bowel management. SUBSCRIBE AllCancerCoeliac DiseaseConstipationIncontinenceIBSInflammatory Bowel DiseasePaediatricsNew chemotherapy-free treatment for bowel cancer made available in ScotlandSeptember 17, 2021NICE draft guidance recommends apalutamide for treating prostate cancerSeptember 8, 2021Novel mechanism links genetic defect in inflammatory bowel disease patients to gut leakinessSeptember 6, 2021New campaign urging people to contact their GP if they have bowel cancer symptomsSeptember 1, 2021NICE approve treatment for untreated metastatic colorectal cancerMay 14, 2021KEYTRUDA approved for gastric or gastroesophageal junction adenocarcinomaMay 6, 2021New digital platform for colorectal patients launched by Chelsea and Westminster HospitalApril 29, 2021Lilly reports positive data from its ulcerative colitis phase 3 trialApril 12, 2021Pembrolizumab added to NHSE COVID interim treatment list for colorectal cancerApril 6, 2021NICE recommends andexanet alfa (ONDEXXYA®▼) for uncontrolled bleeds in the gastrointestinal tractApril 6, 2021GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancersJanuary 18, 2021New data show positive association between Remsima® SC pre-dose level with efficacy outcomesOctober 14, 20204 123456789 5
Novel mechanism links genetic defect in inflammatory bowel disease patients to gut leakinessSeptember 6, 2021
New digital platform for colorectal patients launched by Chelsea and Westminster HospitalApril 29, 2021
NICE recommends andexanet alfa (ONDEXXYA®▼) for uncontrolled bleeds in the gastrointestinal tractApril 6, 2021
GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancersJanuary 18, 2021
New data show positive association between Remsima® SC pre-dose level with efficacy outcomesOctober 14, 2020
